Phytosomal curcumin beneficial for migrainesThe effects of phytosomal curcumin supplementation on clinical symptoms, and inflammatory and oxidative stress biomarkers in patients with migraine: A protocol for a randomized double-blind placebo-controlled trial.
Most Relevant Research
We conducted a randomized, double-blind, placebo-controlled trial to explore the effects of phytosomal curcumin—a special form of turmeric—on patients suffering from migraines. Our aim was to see if this potent antioxidant and anti-inflammatory treatment could help alleviate the frequency, duration, and intensity of migraine headaches.
In our study, 60 participants were divided into two groups. One received 250 mg of phytosomal curcumin daily, while the other group took a placebo made from maltodextrin for eight weeks. We measured various factors before and after the intervention, including the quality of life, sleep quality, mood, and important biomarkers related to inflammation and oxidative stress.
The results suggest that phytosomal curcumin might effectively reduce neuroinflammation, oxidative stress, and even neurotoxicity. This, in turn, could lead to fewer headaches and improve overall well-being for migraine sufferers. The promising nature of this turmeric formulation, which boasts improved absorption and the ability to cross the blood-brain barrier, adds to the excitement around its potential benefits in managing migraines.